Skip to main content

ImageneBio, Inc.

IMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001835579

In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding ImageneBio, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of IMA: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders4641−5
Shares32.7M31.8M−985.8K (−3.0%)
Value$41.9M$42.6M+$646.8K (+1.5%)

New holders (4)

Institutions that held ImageneBio, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to IMA in Q2 2025
InstitutionSharesValue% of portfolio
Royal Bank of Canada16,000$21.0K0.00%
Susquehanna International Group, LLP13,141$17.6K0.00%
Tower Research Capital LLC (TRC)2,275$3.05K0.00%
Wells Fargo & Company500$6700.00%

Sold out (9)

Institutions that held ImageneBio, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of IMA in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Peapod Lane Capital LLC296,437$379.4K
Deuterium Capital Management, LLC80,579$103.1K
BBR Partners, LLC70,000$89.6K
Prudential Financial Inc26,000$33.3K
JustInvest LLC16,952$21.7K
FMR LLC5,063$6.48K
Coldstream Capital Management Inc525$672
Farther Finance Advisors, LLC108$135
Nisa Investment Advisors, LLC69$88